NCT06670950View on ClinicalTrials.gov

A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Healthy
Interventions
DRUG

SYT-510

Oral formulation A fasted

DRUG

SYT-510

Oral formulation B fasted

DRUG

SYT-510

Oral formulation A fed

DRUG

Placebo

Oral formulation

Trial Locations (1)

Unknown

RECRUITING

Richmond Pharmacology Ltd, London

All Listed Sponsors
lead

Synendos Therapeutics AG

INDUSTRY